Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Mercaptopurine

2 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    VICCBMT15150

    01/10/2017

    A Phase 1/2 Multi-Center Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Subjects with Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r ALL) (ZUMA-3)

    Treatment

    COGAALL1231

    05/13/2015

    A Phase III Randomized Trial Investigating Bortezomib NSC# 681239; IND# 58443) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)


    Print this page for your doctor